Ratio Therapeutics Inc, a Boston-based pharmaceutical company, announced on Tuesday that it has named Bill Cupelo as its new chief business officer and D. Scott Holbrook, MS, FSNMMI-TS as its new director.
Cupelo has more than 10 years of experience in sales with a focus on oncology and neurology. He has served as head of Sales at Invicro and vice president of Business Development and Strategic Accounts, and software product manager at Invicro.
Holbrook has 25 plus years of experience in the field of molecular imaging and therapeutics. Presently, he serves as the general manager and chief strategy officer at PharmaLogic.
Nektar Therapeutics agrees sale of Huntsville manufacturing facility and reagent supply business
Insmed receives highest ranking in Science's 2024 Top Employers Survey
OncoZenge partners with Pharmanovia for exclusive BupiZenge commercialization in EMENA regions
Viatris added to Forbes' World's Best Employers 2024 list
Rarity Health named finalist for 21st MM+M Rare Disease Agency of the Year